XSWX:BION (Switzerland)
Â
CE with IsEquityFundamentalDataAvailable = 1 in Gid
CHF
50.6
-0.90 (-1.75%)
Jul 10
Business Description
BB Biotech AG
ISIN : CH0038389992
Share Class Description:
XSWX:BION: CE with IsEquityFundamentalDataAvailable = 1 in GidTotal Employee Number:
73Compare
Compare
Traded in other countries / regions
BION.SwitzerlandBBZA.GermanyBIONz.UKBB.ItalyBBAGF.USA Index Membership
STOXX Europe 600 IPO Date
1996-08-02Description
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 1 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 10.3 | |||||
3-Year Book Growth Rate | 1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -64.32 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 703.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.45 | |||||
9-Day RSI | 63.62 | |||||
14-Day RSI | 65.17 | |||||
3-1 Month Momentum % | -6.45 | |||||
6-1 Month Momentum % | -11.84 | |||||
12-1 Month Momentum % | 33.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.45 | |||||
Dividend Payout Ratio | 0.15 | |||||
3-Year Dividend Growth Rate | -22.4 | |||||
Forward Dividend Yield % | 4.45 | |||||
5-Year Yield-on-Cost % | 2.11 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 4.56 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 97.47 | |||||
FCF Margin % | 48.1 | |||||
OCF Margin % | 48.1 | |||||
ROE % | 34.66 | |||||
ROA % | 34.59 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.48 | |||||
Forward PE Ratio | 14.17 | |||||
PE Ratio without NRI | 3.48 | |||||
Shiller PE Ratio | 25.63 | |||||
PS Ratio | 3.4 | |||||
PB Ratio | 1.06 | |||||
Price-to-Tangible-Book | 1.06 | |||||
Price-to-Free-Cash-Flow | 7.09 | |||||
Price-to-Operating-Cash-Flow | 7.09 | |||||
EV-to-Revenue | 2.98 | |||||
EV-to-FCF | 6.19 | |||||
Price-to-Projected-FCF | 0.61 | |||||
Price-to-Graham-Number | 0.4 | |||||
| Price-to-Net-Cash | 8.04 | |||||
FCF Yield % | 14.11 | |||||
Forward Rate of Return (Yacktman) % | -0.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BB Biotech AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 818.436 | ||
| EPS (TTM) (CHF) | 14.54 | ||
| Beta | 0.2954 | ||
| 3-Year Sharpe Ratio | 0.38 | ||
| 3-Year Sortino Ratio | 0.62 | ||
| Volatility % | 22.32 | ||
| 14-Day RSI | 65.17 | ||
| 14-Day ATR (CHF) | 1.197139 | ||
| 20-Day SMA (CHF) | 47.7425 | ||
| 12-1 Month Momentum % | 33.28 | ||
| 52-Week Range (CHF) | 30.75 - 52 | ||
| Shares Outstanding (Mil) | 55.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BB Biotech AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BB Biotech AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| CHF 2.250000 Cash Dividend | 2026-03-23 | 45.40 (+0.78%) | ||
| CHF 1.800000 Cash Dividend | 2025-03-21 | 34.65 (-1.00%) | ||
| Third quarter earnings results for 2024 | 2024-10-18 07:00 | 37.10 (+0.27%) | ||
| Second quarter earnings results for 2024 | 2024-07-19 07:00 | 43.15 (-0.58%) | ||
| 5:1 Stock Split | 2016-03-29 | 45.18 (+0.00%) | ||
| 10:1 Stock Split | 2001-05-18 | 26.56 (+0.23%) |
Show
Entries
BB Biotech AG Frequently Asked Questions
What is BB Biotech AG(XSWX:BION)'s stock price today?
The current price of XSWX:BION is CHF50.60. The 52 week high of XSWX:BION is CHF52.00 and 52 week low is CHF30.75.
When is next earnings date of BB Biotech AG(XSWX:BION)?
The next earnings date of BB Biotech AG(XSWX:BION) is .
Does BB Biotech AG(XSWX:BION) pay dividends? If so, how much?
The Dividend Yield %  of BB Biotech AG(XSWX:BION) is 4.45% (As of Today), Highest Dividend Payout Ratio of BB Biotech AG(XSWX:BION) was 1.45. The lowest was 0.15. And the median was 0.25. The  Forward Dividend Yield % of BB Biotech AG(XSWX:BION) is 4.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BB Biotech AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers